Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Purushottam M. Dewang
Observed name:
Purushottam Dewang
Observed institutions:
Ewha Womans University,
National Central University,
Jubilant Life Sciences (India)
OpenAlex ID:
A5082153367
Protein Tyrosine Phosphatases and their Inhibitors
2005
·
Purushottam Dewang
, Nai-Mu Hsu
, et al.
·
Current Medicinal Chemistry
·
48
Novel dual LSD1/HDAC6 inhibitors for the treatment of multiple myeloma
2020
·
M Naveen Sadhu
, Dhanalakshmi Sivanandhan
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
41
Synthesis and biological evaluation of 2-pyridyl-substituted pyrazoles and imidazoles as transforming growth factor-β type 1 receptor kinase inhibitors
2010
·
Purushottam M. Dewang
, Dae-Kee Kim
·
Bioorganic & Medicinal Chemistry Letters
·
34
Synthesis and biological evaluation of 4(5)-(6-methylpyridin-2-yl)imidazoles and -pyrazoles as transforming growth factor-β type 1 receptor kinase inhibitors
2010
·
Dae-Kee Kim
, Yeon-Im Lee
, et al.
·
Bioorganic & Medicinal Chemistry
·
31
Validated RP‐HPLC/UV method for the quantitation of abiraterone in rat plasma and its application to a pharmacokinetic study in rats
2012
·
S. Vijay Kumar
, G. Rudresha
, et al.
·
Biomedical Chromatography
·
29
Synthesis and biological evaluation of benzenesulfonamide-substituted 4-(6-alkylpyridin-2-yl)-5-(quinoxalin-6-yl)imidazoles as transforming growth factor-β type 1 receptor kinase inhibitors
2008
·
Dae-Kee Kim
, Sun Hee Jung
, et al.
·
European Journal of Medicinal Chemistry
·
25
Novel dual LSD1/HDAC6 inhibitor for the treatment of cancer
2023
·
Chandru Gajendran
, Subramanyam Janardhan Tantry
, et al.
·
PLoS ONE
·
22
PDF
Traceless Solid-Phase Synthesis of Carbolinones
2004
·
Meei-Shiou Chern
, Ying-Kai Shih
, et al.
·
Journal of Combinatorial Chemistry
·
17
LC–MS/MS-ESI method for simultaneous quantification of darolutamide and its active metabolite, ORM-15341 in mice plasma and its application to a pharmacokinetic study
2017
·
Sreekanth Dittakavi
, Pavan Kumar V.S.P. Nagasuri
, et al.
·
Journal of Pharmaceutical and Biomedical Analysis
·
16
Determination of ulixertinib in mice plasma by LC–MS/MS and its application to a pharmacokinetic study in mice
2016
·
Rajinish Kumar
, P.S. Suresh
, et al.
·
Journal of Pharmaceutical and Biomedical Analysis
·
13
Validation of an LC–MS/MS method for simultaneous detection of four HDAC inhibitors – belinostat, panobinostat, rocilinostat and vorinostat in mouse plasma and its application to a mouse pharmacokinetic study
2016
·
Kalpesh Kumar Giri
, P. S. Suresh
, et al.
·
Biomedical Chromatography
·
10
Synthesis, biological evaluation and molecular modelling of 2,4-disubstituted-5-(6-alkylpyridin-2-yl)-1 H -imidazoles as ALK5 inhibitors
2020
·
Myoung-Soon Park
, Hyun-Ju Park
, et al.
·
Journal of Enzyme Inhibition and Medicinal Chemistry
·
8
PDF
Synthesis and biological evaluation of trisubstituted imidazole derivatives as inhibitors of p38α mitogen-activated protein kinase
2008
·
Dae-Kee Kim
, Jin-Hwi Lim
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
6
Preclinical assessment of Orteronel®, a CYP17A1 enzyme inhibitor in rats
2014
·
Mohd Zainuddin
, A. B. Vinod
, et al.
·
European Journal of Drug Metabolism and Pharmacokinetics
·
5
Protein Tyrosine Phosphatases and Their Inhibitors
2010
·
Yogesh S. Tingare
, Purushottam M. Dewang
, et al.
·
BENTHAM SCIENCE PUBLISHERS eBooks
·
5
Abstract B150: ASN007, a novel oral ERK inhibitor, shows robust antitumor activity in RAS mutant cancer models
2018
·
Sanjeeva P. Reddy
, Dhanalakshmi Sivanandhan
, et al.
·
Molecular Cancer Therapeutics
·
3
Sensitive method for the determination of rocilinostat in small volume mouse plasma by LC‐MS/MS and its application to a pharmacokinetic study in mice
2015
·
Manish Gupta
, Abhishek Dixit
, et al.
·
Biomedical Chromatography
·
3
Abstract 3509: Novel dual inhibitors of LSD1-HDAC for treatment of cancer
2015
·
Dhanalakshmi Sivanandhan
, Sridharan Rajagopalan
, et al.
·
Cancer Research
·
3
Abstract 11: Novel dual inhibitors of LSD1-HDAC6/8 for treatment of cancer
2019
·
Dhanalakshmi Sivanandhan
, Sridharan Rajagopal
, et al.
·
Cancer Research
·
2
Protein Phosphatase: Structural Features, Physiological Significance and Synthetic Inhibitors
2004
·
Purushottam Dewang
, Shao-Zheng Peng
, et al.
·
Current Organic Chemistry
·
2
Abstract 5860: Novel, first-in-class dual inhibitors of lysine specific demethylase 1 (LSD1) and histone deacetylatse 1 (HDAC) for treatment of cancer
2018
·
Dhanalakshmi Sivanandhan
, Sreekala Nair
, et al.
·
Cancer Research
·
1
Abstract C134: EN3356, a novel CYP17A inhibitor for the treatment of castration resistant prostate cancer.
2013
·
Nicholas J. Laping
, Dhanalakshmi Sivanandhan
, et al.
·
Molecular Cancer Therapeutics
·
1
Development and validation of an RP‐HPLC method for the quantitation of Orteronel (TAK‐700), a CYP17A1 enzyme inhibitor, in rat plasma and its application to a pharmacokinetic study
2013
·
Avinash Kumar
, Vijay Kumar S
, et al.
·
Biomedical Chromatography
·
1
Abstract 11: Novel dual inhibitors of LSD1-HDAC6/8 for treatment of cancer
2019
·
Dhanalakshmi Sivanandhan
, Sridharan Rajagopal
, et al.
·
Cancer Chemistry
Abstract 1382: Novel dual inhibitors of LSD1-HDAC6/8 for treatment of cancer
2018
·
Sivanandhan Dhanalakshmi
, Sridharan Rajagopal
, et al.
·
Cancer Research
Show more works
View as search
Works count:
27
Citation count:
326
H-index:
10
I10-index:
11
Year
Topic
Type
